As regards protection against T cell activation, the defense mechanism in genital tract melanoma is similar to that in cutaneous melanoma: the PD-L1 ligand is produced and binds to PD-1 T cell checkpoints on the surface of the tumor cells; this mechanism is also relatively common in vulvar melanoma [29,42,43]. This evidence concerns the gene CD274 and neoplasm.